Showing results (1-10 of 370) with videos related to
Sort By:
Pageof 37
Current Opinion in Neurology|July 14, 2009
Recent advances in motor neuron diseasePhilip Van Damme, Wim RobberechtExpert Opinion on Investigational Drugs|May 13, 2014
Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal deliveryPhilip Van Damme, Wim RobberechtCurrent Opinion in Neurology|August 16, 2013
Clinical implications of recent breakthroughs in amyotrophic lateral sclerosisPhilip Van Damme, Wim RobberechtDisease Models & Mechanisms|May 5, 2017
Modelling amyotrophic lateral sclerosis: progress and possibilitiesPhilip Van Damme, Wim Robberecht, Ludo Van Den BoschAnnals of Neurology|March 26, 2011
Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective studyMaarten Schrooten, Charlotte Smetcoren, Wim Robberecht, et al.Muscle & Nerve|July 21, 2006
Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseasesElke Bogaert, Philip Van Damme, Ludo Van Den Bosch, et al.Neurobiology of Disease|October 19, 2006
Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosisMaria Andries, Philip Van Damme, Wim Robberecht, et al.The European Journal of Neuroscience|June 10, 2010
The neurobiology of amyotrophic lateral sclerosisAndré Bento-Abreu, Philip Van Damme, Ludo Van Den Bosch, et al.Neuroscience Letters|May 22, 2003
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosisPhilip Van Damme, Maarten Leyssen, Geert Callewaert, et al.Journal of Visualized Experiments : Jove|July 10, 2018
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron DegenerationEveliina Pollari, Robert Prior, Wim Robberecht, et al.Pageof 37